Search research articles
Contact Us
Filters
Showing results (1041-1050 of 1,873) with videos related to
Page
of 188
Sort By:
American Heart Journal
|
August 25, 2015
Race and ethnicity influences on cardiovascular and renal events in patients with diabetes mellitus
Eldrin F Lewis, Brian Claggett, Patrick S Parfrey, et al.
Archives of Internal Medicine
|
October 12, 2005
Left ventricular assessment in myocardial infarction: the VALIANT registry
Adrian F Hernandez, Eric J Velazquez, Scott D Solomon, et al.
Hypertension (Dallas, Tex. : 1979)
|
November 21, 2007
Effect of antecedent hypertension and follow-up blood pressure on outcomes after high-risk myocardial infarction
Jens J Thune, James Signorovitch, Lars Kober, et al.
Journal of Cardiac Failure
|
April 9, 2023
The Effect of Sacubitril/Valsartan on Left Ventricular Myocardial Deformation in Heart Failure with Preserved Ejection Fraction (PARAMOUNT trial)
Tor Biering-Sørensen, Mats C Højbjerg Lassen, Amil Shah, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
August 9, 2011
Association between cardiac biomarkers and the development of ESRD in patients with type 2 diabetes mellitus, anemia, and CKD
Akshay S Desai, Robert Toto, Petr Jarolim, et al.
Journal of the American College of Cardiology
|
June 11, 2025
Re-Evaluating Recurrent Events in Heart Failure Trials: Patterns, Prognostic Implications, and Analytical Improvements
Audinga-Dea Hazewinkel, John Gregson, Stuart J Pocock, et al.
American Journal of Medical Genetics. Part A
|
December 9, 2022
Perspectives on the future of dysmorphology
Benjamin D Solomon, Margaret P Adam, Chin-To Fong, et al.
European Journal of Heart Failure
|
July 7, 2022
Biomarker-driven prognostic models in chronic heart failure with preserved ejection fraction: the EMPEROR-Preserved trial
Stuart J Pocock, João Pedro Ferreira, Milton Packer, et al.
Circulation
|
May 5, 2016
Importance of Clinical Worsening of Heart Failure Treated in the Outpatient Setting: Evidence From the Prospective Comparison of ARNI With ACEI to Determine Impact on Global Mortality and Morbidity in Heart Failure Trial (PARADIGM-HF)
Naoki Okumura, Pardeep S Jhund, Jianjian Gong, et al.
Journal of Cardiac Failure
|
February 16, 2023
Rationale, Design and Baseline Characteristics of the PARAGLIDE-HF Trial: Sacubitril/Valsartan vs Valsartan in HFmrEF and HFpEF With a Worsening Heart Failure Event
Robert J Mentz, Jonathan H Ward, Adrian F Hernandez, et al.
Page
of 188
Search research articles
Search
Showing results (1041-1050 of 1,873) with videos related to
Sort By:
Page
of 188
American Heart Journal
|
August 25, 2015
Race and ethnicity influences on cardiovascular and renal events in patients with diabetes mellitus
Eldrin F Lewis, Brian Claggett, Patrick S Parfrey, et al.
Archives of Internal Medicine
|
October 12, 2005
Left ventricular assessment in myocardial infarction: the VALIANT registry
Adrian F Hernandez, Eric J Velazquez, Scott D Solomon, et al.
Hypertension (Dallas, Tex. : 1979)
|
November 21, 2007
Effect of antecedent hypertension and follow-up blood pressure on outcomes after high-risk myocardial infarction
Jens J Thune, James Signorovitch, Lars Kober, et al.
Journal of Cardiac Failure
|
April 9, 2023
The Effect of Sacubitril/Valsartan on Left Ventricular Myocardial Deformation in Heart Failure with Preserved Ejection Fraction (PARAMOUNT trial)
Tor Biering-Sørensen, Mats C Højbjerg Lassen, Amil Shah, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
August 9, 2011
Association between cardiac biomarkers and the development of ESRD in patients with type 2 diabetes mellitus, anemia, and CKD
Akshay S Desai, Robert Toto, Petr Jarolim, et al.
Journal of the American College of Cardiology
|
June 11, 2025
Re-Evaluating Recurrent Events in Heart Failure Trials: Patterns, Prognostic Implications, and Analytical Improvements
Audinga-Dea Hazewinkel, John Gregson, Stuart J Pocock, et al.
American Journal of Medical Genetics. Part A
|
December 9, 2022
Perspectives on the future of dysmorphology
Benjamin D Solomon, Margaret P Adam, Chin-To Fong, et al.
European Journal of Heart Failure
|
July 7, 2022
Biomarker-driven prognostic models in chronic heart failure with preserved ejection fraction: the EMPEROR-Preserved trial
Stuart J Pocock, João Pedro Ferreira, Milton Packer, et al.
Circulation
|
May 5, 2016
Importance of Clinical Worsening of Heart Failure Treated in the Outpatient Setting: Evidence From the Prospective Comparison of ARNI With ACEI to Determine Impact on Global Mortality and Morbidity in Heart Failure Trial (PARADIGM-HF)
Naoki Okumura, Pardeep S Jhund, Jianjian Gong, et al.
Journal of Cardiac Failure
|
February 16, 2023
Rationale, Design and Baseline Characteristics of the PARAGLIDE-HF Trial: Sacubitril/Valsartan vs Valsartan in HFmrEF and HFpEF With a Worsening Heart Failure Event
Robert J Mentz, Jonathan H Ward, Adrian F Hernandez, et al.
Page
of 188